AU2015206520B2 - Identification of functional cell states - Google Patents

Identification of functional cell states Download PDF

Info

Publication number
AU2015206520B2
AU2015206520B2 AU2015206520A AU2015206520A AU2015206520B2 AU 2015206520 B2 AU2015206520 B2 AU 2015206520B2 AU 2015206520 A AU2015206520 A AU 2015206520A AU 2015206520 A AU2015206520 A AU 2015206520A AU 2015206520 B2 AU2015206520 B2 AU 2015206520B2
Authority
AU
Australia
Prior art keywords
cells
cell
tensor
response
phenotypic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015206520A
Other languages
English (en)
Other versions
AU2015206520A1 (en
Inventor
Bartlomiej Rajwa
T. Vincent Shankey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASEDASCIENCES AG
Original Assignee
ASEDASCIENCES AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASEDASCIENCES AG filed Critical ASEDASCIENCES AG
Publication of AU2015206520A1 publication Critical patent/AU2015206520A1/en
Priority to AU2021204419A priority Critical patent/AU2021204419A1/en
Application granted granted Critical
Publication of AU2015206520B2 publication Critical patent/AU2015206520B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/40—Searching chemical structures or physicochemical data
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Physiology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU2015206520A 2014-01-14 2015-01-14 Identification of functional cell states Active AU2015206520B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021204419A AU2021204419A1 (en) 2014-01-14 2021-06-28 Identification of functional cell states

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461927247P 2014-01-14 2014-01-14
US61/927,247 2014-01-14
PCT/US2015/011441 WO2015109003A1 (en) 2014-01-14 2015-01-14 Identification of functional cell states

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2021204419A Division AU2021204419A1 (en) 2014-01-14 2021-06-28 Identification of functional cell states

Publications (2)

Publication Number Publication Date
AU2015206520A1 AU2015206520A1 (en) 2016-07-14
AU2015206520B2 true AU2015206520B2 (en) 2021-07-22

Family

ID=52440877

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2015206520A Active AU2015206520B2 (en) 2014-01-14 2015-01-14 Identification of functional cell states
AU2021204419A Abandoned AU2021204419A1 (en) 2014-01-14 2021-06-28 Identification of functional cell states

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2021204419A Abandoned AU2021204419A1 (en) 2014-01-14 2021-06-28 Identification of functional cell states

Country Status (11)

Country Link
US (3) US11137388B2 (enExample)
EP (1) EP3094974B1 (enExample)
JP (1) JP6606100B2 (enExample)
KR (1) KR102413041B1 (enExample)
AU (2) AU2015206520B2 (enExample)
CA (1) CA2972960C (enExample)
DK (1) DK3094974T3 (enExample)
ES (1) ES2728119T3 (enExample)
IL (1) IL246734B (enExample)
SG (1) SG11201705495XA (enExample)
WO (1) WO2015109003A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3094974B1 (en) * 2014-01-14 2019-02-27 Asedasciences AG Identification of functional cell states
CA2977481C (en) 2015-02-24 2021-02-02 The University Of Tokyo Dynamic high-speed high-sensitivity imaging device and imaging method
EP3372985B1 (en) 2015-10-28 2025-06-25 The University Of Tokyo Analysis device
US10824693B2 (en) 2015-12-10 2020-11-03 Reservoir Labs, Inc. Systems and methods for selective expansive recursive tensor analysis
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
US12300357B2 (en) 2016-12-14 2025-05-13 FlowJo, LLC Applied computer technology for management, synthesis, visualization, and exploration of parameters in large multi-parameter data sets
US11573182B2 (en) 2017-05-25 2023-02-07 FlowJo, LLC Visualization, comparative analysis, and automated difference detection for large multi-parameter data sets
WO2019241443A1 (en) 2018-06-13 2019-12-19 Thinkcyte Inc. Methods and systems for cytometry
US11972858B2 (en) 2019-05-14 2024-04-30 University Of Pittsburgh-Of The Commonwealth System Of Higher Education System and method for characterizing cellular phenotypic diversity from multi-parameter cellular, and sub-cellular imaging data
EP4083603A4 (en) 2019-12-27 2024-04-03 ThinkCyte, Inc. FLOW CYTOMETER PERFORMANCE EVALUATION METHODS AND STANDARD PARTICLE SUSPENSION
WO2021200960A1 (ja) 2020-04-01 2021-10-07 シンクサイト株式会社 観察装置
WO2021200911A1 (ja) 2020-04-01 2021-10-07 シンクサイト株式会社 フローサイトメーター
WO2022026532A1 (en) * 2020-07-30 2022-02-03 Allen Institute Systems, devices, and methods for compound screening using predictive tagging
US20240337647A1 (en) 2021-07-26 2024-10-10 Asedasciences Ag Improved methods for identification of functional cell states
WO2023056481A1 (en) * 2021-10-01 2023-04-06 CAP Diagnostics, LLC, dba Pathnostics Automated methods and systems for rapid identification of target particles
US12105081B2 (en) * 2021-10-20 2024-10-01 Travera, Inc. Treatment response assessment using normalized single cell measurements
IL322273A (en) 2023-01-23 2025-09-01 Asedasciences Ag Improved human-computer interaction systems

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009146036A2 (en) * 2008-04-01 2009-12-03 Purdue Research Foundation Quantification of differences between measured values and statistical validation based on the differences
US8467970B2 (en) * 2000-03-06 2013-06-18 Discoverx Corporation Function homology screening

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5544650A (en) * 1988-04-08 1996-08-13 Neuromedical Systems, Inc. Automated specimen classification system and method
AU6024294A (en) 1993-01-08 1994-08-15 Coulter Corporation Method of using preserved control cells in the calibration of fluorescent and light scatter measurements
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US20050221280A1 (en) 1998-02-02 2005-10-06 Odyssey Thera, Inc. Protein-protein interactions for pharmacological profiling
US7166424B2 (en) 1998-02-02 2007-01-23 Odyssey Thera Inc. Fragments of fluorescent proteins for protein fragment complementation assays
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6998249B1 (en) 1999-09-27 2006-02-14 Pharmacia & Upjohn Company Toxicity screening method
EP1290428A1 (en) 2000-06-02 2003-03-12 Medicometrics APS Method and system for classifying a biological sample
US7146349B2 (en) * 2000-11-06 2006-12-05 International Business Machines Corporation Network for describing multimedia information
WO2004094609A2 (en) 2003-04-23 2004-11-04 Bioseek, Inc. Methods for characterizing signaling pathways and compounds that interact therewith
US20070135997A1 (en) 2003-04-23 2007-06-14 Evangelos Hytopoulos Methods for analysis of biological dataset profiles
WO2008134593A1 (en) * 2007-04-25 2008-11-06 President And Fellows Of Harvard College Molecular circuits
US20130226469A1 (en) 2008-04-01 2013-08-29 Purdue Research Foundation Gate-free flow cytometry data analysis
EP3094974B1 (en) * 2014-01-14 2019-02-27 Asedasciences AG Identification of functional cell states

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8467970B2 (en) * 2000-03-06 2013-06-18 Discoverx Corporation Function homology screening
WO2009146036A2 (en) * 2008-04-01 2009-12-03 Purdue Research Foundation Quantification of differences between measured values and statistical validation based on the differences

Also Published As

Publication number Publication date
US11137388B2 (en) 2021-10-05
DK3094974T3 (da) 2019-05-27
JP6606100B2 (ja) 2019-11-13
AU2021204419A1 (en) 2021-07-22
US11867690B2 (en) 2024-01-09
JP2017505140A (ja) 2017-02-16
US20160370350A1 (en) 2016-12-22
KR102413041B1 (ko) 2022-06-23
ES2728119T3 (es) 2019-10-22
KR20160110444A (ko) 2016-09-21
CA2972960A1 (en) 2015-07-23
US20210364499A1 (en) 2021-11-25
SG11201705495XA (en) 2017-08-30
EP3094974B1 (en) 2019-02-27
EP3094974A1 (en) 2016-11-23
AU2015206520A1 (en) 2016-07-14
IL246734A0 (en) 2016-08-31
WO2015109003A1 (en) 2015-07-23
HK1231553A1 (en) 2017-12-22
US20150198584A1 (en) 2015-07-16
IL246734B (en) 2019-06-30
CA2972960C (en) 2022-01-11

Similar Documents

Publication Publication Date Title
US11867690B2 (en) Identification of functional cell states
O'Neill et al. Flow cytometry bioinformatics
Sirenko et al. Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity
JP4354977B2 (ja) フローサイトメーター多次元データセット内のデータの離散母集団（例えば、クラスター）を識別する方法
CN103562920B (zh) 混合模型密度设门中的邻域阈值选取
Leelatian et al. Characterizing phenotypes and signaling networks of single human cells by mass cytometry
US20120215487A1 (en) Methods and apparatus related to gate boundaries within a data space
Robinson et al. Computational analysis of high-throughput flow cytometry data
Tsiper et al. Differential mitochondrial toxicity screening and multi-parametric data analysis
US20130226469A1 (en) Gate-free flow cytometry data analysis
US20240337647A1 (en) Improved methods for identification of functional cell states
Marsh‐Wakefield et al. Making the most of high‐dimensional cytometry data
JP2013529891A (ja) 無標識オンターゲット薬理学方法
Veschini et al. High-content imaging to phenotype human primary and ipsc-derived cells
US20050282208A1 (en) Cellular phenotype
HK1231553B (en) Identification of functional cell states
US20230137843A1 (en) Holographic video microscopy cell viability assay
Schauer et al. A novel organelle map framework for high-content cell morphology analysis in high throughput
US20050014131A1 (en) Methods and apparatus for investigating side effects
Aghaeepour et al. Flow cytometry bioinformatics
Forsgren et al. The time dimension matters: Improving mode of action classification with live-cell imaging
Chen Evaluating the performance of between-sample heterogeneity identification algorithms in large-scale flow cytometry data analysis
CN108267571A (zh) 一种血液种属判别的方法
WO2025170878A1 (en) Methods for high-throughput drug screens at clonal resolution
MATTON Automating flow cytometry data analysis using clustering techniques

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)